Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heike Brinkhaus

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Nature Medicine|March 6, 2012
Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loopNicola Aceto, Nina Sausgruber, Heike Brinkhaus, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2013
Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signalingAdrian Britschgi, Anke Bill, Heike Brinkhaus, et al.
Nature|January 10, 2017
The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERαAdrian Britschgi, Stephan Duss, Sungeun Kim, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Nature Medicine|March 6, 2012
Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loopNicola Aceto, Nina Sausgruber, Heike Brinkhaus, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2013
Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signalingAdrian Britschgi, Anke Bill, Heike Brinkhaus, et al.
Nature|January 10, 2017
The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERαAdrian Britschgi, Stephan Duss, Sungeun Kim, et al.
Pageof 2